Squarepoint’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Squarepoint’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,492	Closed	-$167K	–	3963
2022 Q4	$167K	Sell	13,492 -708	-5%	-$10K	﹤0.01%	2844
2022 Q3	$198K	Sell	14,200 -68,549	-83%	-$1.1M	﹤0.01%	2697
2022 Q2	$1.14M	Buy	82,749 +41,941	+103%	+$672K	0.01%	1525
2022 Q1	$664K	Sell	40,808 -20,520	-33%	-$321K	﹤0.01%	1842
2021 Q4	$999K	Sell	61,328 -6,176	-9%	-$104K	﹤0.01%	1696
2021 Q3	$1M	Buy	67,504 +34,888	+107%	+$558K	﹤0.01%	1558
2021 Q2	$651K	Sell	32,616 -35,686	-52%	-$707K	﹤0.01%	1953
2021 Q1	$1.58M	Buy	+68,302	New	+$1.9M	0.01%	1211
2020 Q4	–	Sell	-18,300	Closed	-$759K	–	3358
2020 Q3	$759K	Buy	18,300 +5,433	+42%	+$250K	0.01%	1148
2020 Q2	$616K	Buy	12,867 +703	+6%	+$54.3K	0.01%	1189
2020 Q1	$766K	Buy	+12,164	New	+$1.09M	0.02%	839
2019 Q4	–	Sell	-17,979	Closed	-$1.19M	–	2900
2019 Q3	$1.19M	Buy	+17,979	New	+$1.21M	0.01%	1105
2019 Q1	–	Sell	-3,399	Closed	-$343K	–	2518
2018 Q4	$343K	Buy	3,399 +118	+4%	+$12.2K	﹤0.01%	1439
2018 Q3	$415K	Buy	+3,281	New	+$347K	0.01%	1384
2018 Q1	–	Sell	-62,445	Closed	-$3.65M	–	2266
2017 Q4	$3.65M	Buy	+62,445	New	+$3.94M	0.06%	356
2017 Q3	–	Sell	-30,865	Closed	-$3.74M	–	1956
2017 Q2	$3.74M	Buy	30,865 +24,265	+368%	+$2.81M	0.07%	331
2017 Q1	$746K	Buy	6,600 +1,400	+27%	+$163K	0.02%	712
2016 Q4	$565K	Buy	5,200 +2,900	+126%	+$345K	0.02%	755
2016 Q3	$379K	Buy	+2,300	New	+$363K	0.03%	658
2016 Q2	–	Sell	-2,900	Closed	-$373K	–	1399
2016 Q1	$373K	Buy	+2,900	New	+$342K	0.03%	739

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Squarepoint's ICPT Position: Q1 2023 in Review

Squarepoint sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 13,492 shares — an estimated $167K sold.

Squarepoint first reported a position in ICPT in Q1 2016 and held it in 20 quarters. The position peaked at $3.74M in Q2 2017. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

Squarepoint reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 13,492 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $167K.
Squarepoint first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and held it in 20 quarters.
Squarepoint's Intercept Pharmaceuticals, Inc. position peaked at $3.74M in Q2 2017.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.